Table: Kyorin Pharmaceutical -2022/23 group results

Kyorin Pharmaceutical

11/05/2023 07:00

May 11 (Reuters)- 
          Kyorin Pharmaceutical Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          113.27          105.53         116.20        53.70    
               (+7.3 pct)                     (+2.6 pct)    (+9.4 pct) 
  Operating        5.12            5.01           6.00       600 mln   
               (+2.3 pct)                     (+17.1 pct)  (-22.9 pct) 
  Recurring        5.83            5.57           6.50       900 mln   
               (+4.6 pct)                     (+11.5 pct)  (-23.2 pct) 
  Net
  Net              4.72            3.93           4.90       700 mln   
               (+20.1 pct)                    (+3.7 pct)   (-43.7 pct) 
  EPS           82.44 yen       68.62 yen      85.51 yen    12.22 yen  
  Ann Div       52.00 yen       52.00 yen      52.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen               
  -Q4 Div       32.00 yen       32.00 yen      32.00 yen               
  
  NOTE - Kyorin Pharmaceutical Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T